Anchored by the UAB Center for AIDS Research (CFAR), now in its 30th year of NIH funding, and by the 1917 Clinic, the Division oversees research ranging from the advancement of basic science in search of a cure to clinical trials evaluating new antiretroviral agents. In addition to providing primary and specialty management for persons living with HIV/AIDS, the 1917 Clinic conducts clinical trials on a range of new treatments for HIV/AIDS. Research efforts are increasingly also focused on critical HIV-associated conditions that have accompanied our success in preventing HIV-associated mortality, namely, metabolic syndromes, cardiovascular events, and non-AIDS-associated malignancies.

Care Continuum - 90/90/90

UAB CFAR’s Ending HIV in Alabama Scientific Working Group (SWG) focuses behavioral and biomedical research engaging clinical investigators, public health researchers and advocates, community stakeholders and consumers with the goal of reaching the United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 targets across Alabama. These targets consist of diagnosing at least 90% of those living with HIV, 90% of those diagnosed receiving antiretroviral therapy (ART), and of those on ART, 90% achieving viral suppression. The SWG promotes interdisciplinary research in this especially vulnerable region through: 1) development of novel approaches to improve outcomes in prevention, testing, linkage to care, retention in care, and viral suppression; 2) implementation of evidence-based interventions through coordination of interdisciplinary teams; and 3) recruitment and mentoring of trainees and early stage investigators in epidemiologic and implementation science research aimed at eliminating HIV in Alabama.